These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 16121709

  • 1. Glycolytic inhibitor, 2-deoxy-D-glucose, does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro.
    Swamy RK, Manickam J, Adhikari JS, Dwarakanath BS.
    Indian J Exp Biol; 2005 Aug; 43(8):686-92. PubMed ID: 16121709
    [Abstract] [Full Text] [Related]

  • 2. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells.
    Varshney R, Dwarakanath B, Jain V.
    Int J Radiat Biol; 2005 May; 81(5):397-408. PubMed ID: 16076755
    [Abstract] [Full Text] [Related]

  • 3. Differential modification of radiation damage in 5-bromo-2-deoxy-uridine sensitized human glioma cells and PHA-stimulated peripheral leukocytes by 2-deoxy-D-glucose.
    Kalia VK, Devi NK.
    Indian J Exp Biol; 1994 Sep; 32(9):637-42. PubMed ID: 7814043
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide protects thymocytes from gamma-irradiation-induced apoptosis in correlation with inhibition of p53 upregulation and mitochondrial damage.
    Chen Y, Stanford A, Simmons RL, Ford HR, Hoffman RA.
    Cell Immunol; 2001 Nov 25; 214(1):72-80. PubMed ID: 11902831
    [Abstract] [Full Text] [Related]

  • 5. Modulatory action of 2-deoxy-D-glucose on mitomycin C-and 4-nitroquinoline-1-oxide-induced genotoxicity in Swiss albino mice in vivo.
    Mohapatra R, Ramesh A, Jayaraman G, Santhiya ST, Gopinath PM.
    J Cancer Res Ther; 2009 Sep 25; 5 Suppl 1():S53-6. PubMed ID: 20009296
    [Abstract] [Full Text] [Related]

  • 6. [Apoptotic characteristics of spleen lymphocyte in mice irradiated by lethal dose and its relationship to the expression of Bax and Bcl-XL proteins].
    Cui YF, Ding YQ, Zhang Y, Xu H, Jin W, Liu XL, Dong B, Mao JP, Mao BZ.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Feb 25; 17(2):109-12. PubMed ID: 15698498
    [Abstract] [Full Text] [Related]

  • 7. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
    Kalia VK, Prabhakara S, Narayanan V.
    J Cancer Res Ther; 2009 Sep 25; 5 Suppl 1():S57-60. PubMed ID: 20009297
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Potentiation of radiation effects in plateau phase human glioma cells by combination of metabolic inhibitors.
    Kalia VK.
    Indian J Exp Biol; 1993 Apr 25; 31(4):312-5. PubMed ID: 8359829
    [Abstract] [Full Text] [Related]

  • 11. Effects of 5-bromo-2-deoxy-uridine and 2-deoxy-D-glucose on the radiosensitivity of proliferating transformed mammalian cells.
    Kalia VK, Jain V.
    Indian J Exp Biol; 1991 Sep 25; 29(9):826-30. PubMed ID: 1794865
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
    Dwarakanath BS, Adhikari JS, Jain V.
    Int J Radiat Oncol Biol Phys; 1999 Mar 15; 43(5):1125-33. PubMed ID: 10192364
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
    Dwarakanath BS.
    J Cancer Res Ther; 2009 Sep 15; 5 Suppl 1():S27-31. PubMed ID: 20009290
    [Abstract] [Full Text] [Related]

  • 17. Ascorbic acid 2-glucocide reduces micronucleus induction in distant splenic T lymphocytes following head irradiation.
    Kinashi Y, Tanaka H, Masunaga S, Suzuki M, Kashino G, Yong L, Takahashi S, Ono K.
    Mutat Res; 2010 Jan 15; 695(1-2):69-74. PubMed ID: 20006734
    [Abstract] [Full Text] [Related]

  • 18. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme.
    Singh D, Banerji AK, Dwarakanath BS, Tripathi RP, Gupta JP, Mathew TL, Ravindranath T, Jain V.
    Strahlenther Onkol; 2005 Aug 15; 181(8):507-14. PubMed ID: 16044218
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose.
    Farooque A, Afrin F, Adhikari JS, Dwarakanath BS.
    J Cancer Res Ther; 2009 Sep 15; 5 Suppl 1():S32-5. PubMed ID: 20009291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.